Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-IDH2 antibody (ab94359)

Anti-IDH2 antibody (ab94359)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Anti-RECQ1 antibody (ab89817)
Product image
Anti-TIPIN antibody (ab229329)
Product image
HRP Anti-Fluorescein antibody (ab6656)
Product image
Anti-Ku70 antibody [EPR4026] - BSA and Azide free (ab247695)

Images

  • Western blot - Anti-IDH2 antibody (ab94359)
    Western blot - Anti-IDH2 antibody (ab94359)

    Lane 1: Wild-type HAP1 cell lysate (20 µg)
    Lane 2: IDH2 knockout HAP1 cell lysate (20 µg)
    Lane 3: K562 cell lysate (20 µg)
    Lane 4: HepG2 cell lysate (20 µg)
    Lanes 1 - 4: Merged signal (red and green). Green - ab94359 observed at 47 kDa. Red - loading control, ab8245, observed at 37 kDa.
    ab94359 was shown to recognize IDH2 when IDH2 knockout samples were used, along with additional cross-reactive bands. Wild-type and IDH2 knockout samples were subjected to SDS-PAGE. ab94359 at a concentration of 1ug/mL and ab8245 (loading control to GAPDH) diluted to 1/2000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.

  • Western blot - Anti-IDH2 antibody (ab94359)
    Western blot - Anti-IDH2 antibody (ab94359)
    All lanes : Anti-IDH2 antibody (ab94359) at 1 µg/ml

    Lane 1 : Human heart tissue lysate - total protein (ab29431)
    Lane 2 : Human skeletal muscle tissue lysate - total protein (ab29330)
    Lane 3 : Human liver tissue lysate - total protein (ab29889)
    Lane 4 : Human brain tissue lysate - total protein (ab29466)
    Lane 5 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate
    Lane 6 : DU 145 (Human prostate carcinoma cell line) Whole Cell Lysate
    Lane 7 : SHSY-5Y (Human neuroblastoma cell line) Whole Cell Lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 51 kDa
    Observed band size: 47 kDa
    why is the actual band size different from the predicted?
    Additional bands at: 35 kDa. We are unsure as to the identity of these extra bands.


    Exposure time: 30 seconds


    The predicted molecular weight of the IDH2 protein is 51-kDa. However, the protein sequence contains a 39 residue transit peptide at the N-terminus. This might explain the migration of the protein at a lower molecular weight than expected.
  • Immunocytochemistry/ Immunofluorescence - Anti-IDH2 antibody (ab94359)
    Immunocytochemistry/ Immunofluorescence - Anti-IDH2 antibody (ab94359)
    ICC/IF image of ab94359 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab94359, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 100% methanol fixed (5 min) MCF7 cells at 1µg/ml, and in 4% PFA fixed (10 min) HepG2 cells at 1µg/ml.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-IDH2 antibody (ab94359)

  •  
  • Product image

    Anti-IDH2 antibody (ab55271)

    Applications: Flow Cyt, ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-IDH2 antibody [EPR7577] - BSA and Azide free (ab230796)

    Applications: Flow Cyt, IHC-P, WB

  •  
  • Product image

    Anti-IDH2 antibody [EPR7577] (ab131263)

    Applications: Flow Cyt, IHC-P, WB

  •  
  • Product image

    PE Anti-IDH2 antibody [EPR7577] (ab212122)

    Applications: Flow Cyt

  •  
  • Product image

    Anti-IDH2 antibody (ab109588)

    Applications: WB

  •  
  • Product image

    Anti-IDH2 antibody (ab233446)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-IDH2 antibody [EPR7576] (ab129180)

    Applications: Flow Cyt, IHC-P, WB

  •  
  • Product image

    Anti-IDH2 antibody (ab177512)

    Applications: IP, WB

  •  
  • Product image

    Anti-IDH2 antibody [EPR7576] - BSA and Azide free (ab246343)

    Applications: Flow Cyt, IHC-P, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Endo G antibody [EP1665Y] (ab76122)

  •  
  • Product image

    Anti-Ubiquitin antibody (ab7780)

  •  
  • Product image

    Anti-AFM antibody [EPR19383] (ab201034)

  •  
  • Product image

    Anti-ADX antibody [EPR4630] (ab109312)

  •  
  • Product image

    Anti-PAPSS2 antibody (ab155585)

  •  
  • Product image

    Anti-FAM210A antibody (ab151142)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.